4//SEC Filing
Verelst Luc 4
Accession 0000899243-21-025828
CIK 0001662244other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 8:55 PM ET
Size
19.2 KB
Accession
0000899243-21-025828
Insider Transaction Report
Form 4
Wepaven BV
10% Owner
Transactions
- Purchase
Common Stock
2021-06-22$18.00/sh+277,777$4,999,986→ 3,536,803 total - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,443 underlying) - Conversion
Common Stock
2021-06-22+3,259,026→ 3,259,026 total - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying)
DF II GP Sarl
10% Owner
Transactions
- Conversion
Common Stock
2021-06-22+3,259,026→ 3,259,026 total - Purchase
Common Stock
2021-06-22$18.00/sh+277,777$4,999,986→ 3,536,803 total - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying) - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,443 underlying)
IHL SA
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying) - Conversion
Common Stock
2021-06-22+3,259,026→ 3,259,026 total - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,443 underlying) - Purchase
Common Stock
2021-06-22$18.00/sh+277,777$4,999,986→ 3,536,803 total
Verelst Luc
10% Owner
Transactions
- Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,443 underlying) - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying) - Conversion
Common Stock
2021-06-22+3,259,026→ 3,259,026 total - Purchase
Common Stock
2021-06-22$18.00/sh+277,777$4,999,986→ 3,536,803 total
Naesens Janwillem
10% Owner
Transactions
- Conversion
Common Stock
2021-06-22+3,259,026→ 3,259,026 total - Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying) - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,443 underlying) - Purchase
Common Stock
2021-06-22$18.00/sh+277,777$4,999,986→ 3,536,803 total
Droia Invest II SCSp
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2021-06-22−10,000,000→ 0 total→ Common Stock (2,933,583 underlying) - Conversion
Series C Convertible Preferred Stock
2021-06-22−1,109,368→ 0 total→ Common Stock (325,443 underlying) - Purchase
Common Stock
2021-06-22$18.00/sh+277,777$4,999,986→ 3,536,803 total - Conversion
Common Stock
2021-06-22+3,259,026→ 3,259,026 total
Footnotes (2)
- [F1]Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date.
- [F2]Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
Documents
Issuer
Cyteir Therapeutics, Inc.
CIK 0001662244
Entity typeother
Related Parties
1- filerCIK 0001867886
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 8:55 PM ET
- Size
- 19.2 KB